• 1
    Anitschkow N: Überdie Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose. Beitr z Path Anal uz Allg Path 56, 379 (1913).
  • 2
    Anitschkow N, Chalatow S: Über experimentelle Cholesterinsteatose und ihre Bedeutung fur die Entstehung einiger pathologischer Prozesse. Centralbl Allg Path v Path Anat 24, 1 (1913).
  • 3
    Neufeld HN, Goldbourt U: Coronary heart disease: Genetic aspects. Circulation 67, 943 (1983).
  • 4
    Packham MA, Rowsell HC, Jorgensen L, Mustard JF: Localized protein accumulation in the wall of the aorta. Exp Mol Pathol 7, 214 (1967).
  • 5
    Bell FP, Adamson I, Schwartz CJ: Aortic endothelial permeability to albumin: Focal and regional patterns of uptake and transmural distribution of 125I-albumin in the young pig. Exp Mol Pathol 20, 57 (1974).
  • 6
    Bell FP, Gallus AS, Schwartz CJ: Focal and regional patterns of uptake and the transmural distribution of 125I-fibrinogen in the pig aorta in vivo. Exp Mol Pathol 20, 281 (1974).
  • 7
    Feldman DL, Hoff HF, Gerrity RG: Immunohistochemical localization of Apo B in aortas from hyperlipidemic swine. Preferential accumulation in lesion-prone areas. Arch Pathol Lab Med 108, 817 (1984).
  • 8
    Hoff HF, Gerrity RG, Naito HK, Dusek DM: Quantitation of Apo B in aortas of hypercholesterolemic swine. Lab Invest 48, 492 (1983).
  • 9
    Caplan BA, Schwartz CJ: Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta. Atherosclerosis 17, 401 (1973).
  • 10
    Caplan BA, Gerrity RG, Schwartz CJ: Endothelial cell morphology in focal areas of in vivo Evans Blue uptake in the young pig aorta. I. Quantitative light microscopic findings. Exp Mol Pathol 21, 102 (1974).
  • 11
    Gerrity RG, Richardson M, Somer JB, Bell FP, Schwartz CJ: Endothelial cell morphology in areas of in vivo Evans Blue uptake in the young pig aorta. II. Ultrastructure of the intima in areas of differing permeability to proteins. Am J Pathol 89, 313 (1977).
  • 12
    Gerrity RG, Naito HK, Richardson M, Schwartz CJ: Dietary-induced atherogenesis in swine. I. Morphology of the intima in prelesion stages. Am J Pathol 95, 775 (1979).
  • 13
    McGill HC, Geer JC, Holman RL: Sites of vascular vulnerability in dogs demonstrated by Evans Blue. AMA Arch Pathol 64, 303 (1957).
  • 14
    Fry DL: Responses of the arterial wall to certain physical factors. In Atherogenesis: Initiating Factors. Ciba Foundation Symposium 12. Elsevier, Amsterdam, London, New York (1973) 93.
  • 15
    Day AJ, Bell FP, Schwartz CJ: Lipid metabolism in focal areas of normal-fed and cholesterol-fed pig aorta. Exp Mol Pathol 21, 179 (1974).
  • 16
    Bell FP, Day AJ, Gent M, Schwartz CJ: Differing patterns of cholesterol accumulation and 3H-cholesterol influx in areas of the cholesterol-fed pig aorta identified by Evans Blue dye. Exp Mol Pathol 22, 366 (1975).
  • 17
    Jauchem JR, Lopez M, Sprague EA, Schwartz CJ: Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol 37, 166 (1982).
  • 18
    Valente AJ, Fowler SR, Sprague EA, Kelley JL, Suenram CA, Schwartz CJ: Initial characterization of a peripheral blood mononuclear cell chemoattractant derived from cultured arterial smooth muscle cells. Am J Pathol 117, 409 (1984).
  • 19
    Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwartz CJ: Purification of a monocyte chemotactic factor (SMC-CF) secreted by non-human primate vascular smooth muscle cells in culture. Biochemistry 27, 4162 (1988).
  • 20
    Cushing SD, Berliner JA, Valente AJ, Territo MC, Mahamad N, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87, 5134 (1990).
  • 21
    Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoprotein: A potential role in recruitment and retention of monocyte/macrophages in atherogenesis. Proc Natl Acad Sci USA 84, 2995 (1987).
  • 22
    Schwartz CJ, Somer JB, Gerrity RG: Initial events in atherogenesis. In Very Early Recognition of Coronary Heart Disease (Eds. McDonaldL, GoodwinJ, ResnekovL). Excerpta Medica, Amsterdam-Oxford (1978) 47.
  • 23
    Sprague EA, Edwards EH, Valente AJ, Suenram CA, Kerbacher JJ, Schwartz CJ: Modified low density lipoprotein (acetyl-LDL) endocytosis II: Influence of the multivalent ligand, cationized ferritin on cultured cells. Exp Mol Pathol 48, 373 (1988).
  • 24
    Lin S-J, Jan K-M, Weinbaum S, Chien S: Transendothelial transport of low density lipoprotein in association with cell mitosis in rat aorta. Arteriosclerosis 9, 230 (1989).
  • 25
    Schwenke DC, Carew TE: Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 9, 895 (1989).
  • 26
    Schwenke DC, Carew TE: Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9, 908 (1989).
  • 27
    Yoshimura T, Robinson EA, Tanaka S, Appella E, Leonard EJ: Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human peripheral blood mononuclear leukocytes. J Immunol 142, 1956 (1989).
  • 28
    Shaft S, Cusack NJ, Born GVR: Increased uptake of methylated low-density lipoprotein induced by noradrenaline in carotid arteries of anaesthetized rabbits. Proc R Soc Lond B 235, 289 (1989).
  • 29
    Rozek MM, Valente AJ, Cayatte AJ, Sprague EA, Schwartz CJ: The influence of smooth muscle cell-derived monocyte chemotactic protein (MCP-I) on monocyte adherence to cultured vascular endothelial cells. Arteriosclerosis 10, 758a (1990).
  • 30
    Schwartz CJ, Sprague EA, Kelley JL, Valente AJ, Suenram CA: Aortic intimal monocyte recruitment in the normo and hypercholesterolemic baboon. Papio cynocephalus: An ultrastructural study: Implications in athcrogenesis. Virchows Arch A 405, 175 (1985).
  • 31
    Schwartz CJ: Perspectives on coronary artery disease: Aetiology, pathogenesis and unresolved problems. In Coronaries and Cholesterol (Eds. CliffWJ, SchoeflGI). Chapman and Hall Medical, London (1989) 1.
  • 32
    Edelson PJ: Monocytes and macrophages: Aspects of their cell biology. In The Cell Biology of Inflammation (Ed. WeissmannG). Elsevier-North Holland Biomedical Press, Amsterdam (1980) 469.
  • 33
    Davies P, Bonney RJ: The secretion of hydrolytic-enzyme by mononuclear phagocytes. In The Cell Biology of Inflammation (Ed. WeissmannG). Elsevier-North Holland Biomedical Press, Amsterdam (1980) 497.
  • 34
    Fowler SD, Mayer EP, Greenspan P: Foam cells and atherogenesis. Ann NY Acad Sci 454, 79 (1985).
  • 35
    Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Suenram CA, Rozek MM: Atherosclerosis as an inflammatory process: The roles of the monocyte-macrophage. Ann NY Acad Sci 454, 115 (1985).
  • 36
    Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Suenram CA, Graves DT, Rozek MM, Edwards EH, Delgado R: Monocyte-macrophage participation in athcrogenesis: Inflammatory components of pathogenesis. Sem Throm Hemosta 12, 79 (1986).
  • 37
    Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76, 333 (1979).
  • 38
    Kelley JL, Suenram CA, Rozek MM, Schwartz CJ: Granuloma macrophages from WHHL rabbits accumulate esterified cholesterol and become foam cells in the absence of a functional LDL receptor. Artheriosclerosis 9, 744a (1989).
  • 39
    Rosenfeld ME, Tsukada T, Gown AM, Ross R: Fatty streak initiation in Watanabe heritable hyperlipidemic and comparably hyper-cholesterolemic fat-fed rabbits. Arteriosclerosis 7, 9 (1987).
  • 40
    Brown MS, Basu SK, Falck JR, Ho YK, Goldstein JL: The scavenger cell pathway for lipoprotein degradation: Specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J Supramolec Sir 13, 67 (1980).
  • 41
    Haberland ME, Oleh CL, Fogelman AM: Role of lysines in mediating interaction of modified low density lipoproteins with the scavenger receptor of human monocyte macrophages. J Biol Chem 259, 11305 (1984).
  • 42
    Henricksen T, Mahoney EM, Steinberg D: Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78, 6499 (1981).
  • 43
    Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipid. Proc Natl Acad Sci USA 81, 3883 (1984).
  • 44
    Parthasarathy S: Oxidation of low density lipoprotein by thiol compounds leads to its recognition by the acetyl LDL receptor. Biochim Biophys Acta 917, 337 (1987).
  • 45
    Fogelman AM, Shechter I, Seager J, Hokom M, Child JS, Edwards PA: Malondialdehyde alteration of low density lipoprotein leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci USA 77, 2214 (1980).
  • 46
    Brown MS, Goldstein JL: Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 52, 223 (1983).
  • 47
    Stein O, Stein Y: Bovine aortic endothelial cells display macrophage-like properties towards acetylated 125I-labelled low density lipoprotein. Biochim Biophys Acta 620, 631 (1980).
  • 48
    Sprague EA, Logan S, Edwards EH, Schwartz CJ, Nerem RM: Enhanced low density lipoprotein (LDL) receptor expression in cultured bovine arterial endothelial cells (BAEC) exposed to elevated fluid-imposed laminar wall shear stress. Phys Med Biol 33 (suppl 1), 252 (1988).
  • 49
    Via DP, Dresel HA, Cheng S-L, Gotto AM, Jr: Murine macrophage tumors are a source of a 260,000-dalton acetyl-low density lipoprotein receptor. J Biol Chem 260, 7379 (1985).
  • 50
    Via DP, Dresel HA, Gotto AM Jr: Isolation and assay of the AcLDL receptor. In Methods in Enzymology, Cell Biology of Plasma Lipoproteins, Vol 129, Part B (Eds. AlbersJJ, SegrestJP). New York, Academic Press (1986) 216.
  • 51
    Dresel HA, Friedrich E, Via DP, Sinn H, Ziegler R, Schettler G: Binding of acetylated low density lipoprotein and maleylated bovine serum albumin to the rat liver: One or two receptors? EMBO J 6, 319 (1987).
  • 52
    Kodama T, Reddy P, Kishimoto C, Krieger M: Purification and characterization of a bovine acetyl low density lipoprotein receptor. Proc Natl Acad Sci USA 85, 9238 (1988).
  • 53
    Kodama TK, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343, 531 (1990).
  • 54
    Rohrer L, Freeman M, Kodama T, Penman M, Krieger M: Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 343, 570 (1990).
  • 55
    Kelley JL, Kerbacher JJ, Schwartz CJ: Purification to homogeneity of the acetyl-LDL “Scavenger” receptor from rabbit carrageenan granulomas. Circulation 78, 13a (1988).
  • 56
    Bom GVR, Shafi S, Cusack NJ: Determinants of the atherogenic flux of low-density lipoprotein into arteries. Arzneim-Forsch/Drug Res 40, 354 (1990).
  • 57
    Chamley-Campbell J, Cambell GR, Ross R: The smooth muscle cell in culture. Physiol Rev 59, 1 (1979).
  • 58
    Stary HC: Changes in the cells of atherosclerotic lesions as advanced lesions evolve in coronary arteries of children and young adults. In Palhobiology of the Human Atherosclerotic Plaque (Eds. GlagovS, NewmanWPIII, SchafferSA). Springer-Verlag, New York (1990) 93.
  • 59
    Woolf N, Carstairs KC: Infiltration and thrombosis in atherogenesis. A study using immunofluorescent techniques. Am J Pathol 51, 373 (1967).
  • 60
    Woolf N: Thrombosis and atherosclerosis. In The Thrombotic Process in Atherogenesis (Eds. ChandlerAB, EureniusK, McMillanGC, NelsonCB, SchwartzCJ, WesslerS). Plenum Publishing, New York (1978) 145.
  • 61
    Schwartz CJ, Mitchell JRA: Cellular infiltration of the human arterial adventitia associated with atheromatous plaques. Circulation 26, 73 (1962).
  • 62
    Schwartz CJ, Ardlie NG, Carter RF, Paterson JC: Gross aortic sudanophilia and hemosiderin deposition. A study on infants, children, and young adults. Arch Pathol 83, 325 (1967).
  • 63
    Mitchell JRA, Schwartz CJ: Arterial Disease. Blackwell Scientific Publications, Oxford (1965) 411, XV.
  • 64
    Hessler JR, Morel DW, Lewis LJ, Chisolm GM: Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3, 215 (1983).
  • 65
    Fielding PE, Fielding CJ, Havel RJ, Kane JP, Tun P: Cholesterol net transport, esterification, and transfer in human hyperlipidemic plasma. J Clin Invest 71, 449 (1983).
  • 66
    Glomset JA: The plasma lecithin: Cholesterol acyltransferase reaction. J Lipid Res 9, 155 (1968).
  • 67
    Carew TE, Schwenke DC, Steinberg D: Antiatherogenic effects of Probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks, and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic (WHHL) rabbit. Proc Natl Acad Sci USA 84, 7725 (1987).
  • 68
    Steinberg D, Parthasarathy S, Carew T, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320, 915 (1989).
  • 69
    McPherson R: Cholesterol ester transfer protein and hypercholesterolemia. Lipid Letter 6 (6) (1990).
  • 70
    Cathcart MK, Morel DW, Chisolm GM: Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukocyte Biol 38, 341 (1985).
  • 71
    Ross R, Raines EW, Bowen-Pope DF: The biology of platelet derived growth factor. Cell 46, 155 (1986).
  • 72
    Ross R: Mechanisms of atherosclerosis—a review. Adv Nephrol 19, 79 (1990).
  • 73
    Ross R: The pathogenesis of atherosclerosis—an update. N Engl J Med 314, 488 (1986).
  • 74
    Bendilt EP, Benditt JM: Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70, 1753 (1973).
  • 75
    Benditt EP: The monoclonal theory of atherogenesis. Atherosclerosis Reviews 3 (Eds. PaolettiR, GottoAM). Raven Press, New York (1978) 77.
  • 76
    Pearson TA, Wang A, Solez K, Heptinstall RH: Clonal characteristics of fibrous plaques and fatty streaks from human aortas. Ant J Pathol 81, 379 (1975).
  • 77
    Thomas WA, Janakidevi K, Reiner JM, Florentin RA: Some aspects of population dynamics of arterial smooth muscle cells in atherogenesis. In Atherosclerosis Reviews 3 (Eds. PaolettiR., GottoAM). Raven Press, New York (1978) 87.
  • 78
    Godeny EK, Sprague EA, Schwartz CJ, Gauntt CJ: Coxsackieviruses group B replication in cultured fetal baboon aortic smooth muscle cells. J Med Virol 20, 135 (1986).
  • 79
    Fabricant CG: Herpesvirus-induced atherosclerosis. Diabetes 30 (suppl 2), 29 (1981).
  • 80
    Leung DYM, Glagov S, Mathews MB: A new in vitro system for studying cell response to mechanical stimulation. Exp Cell Res 109, 285 (1977).
  • 81
    Adams CWM: Tissue changes and lipid entry in developing atheroma. In Atherogenesis: Initiating Factors. Ciba Foundation Symposium 12, (1973) 30.
  • 82
    Abdulla YH, Adams CWM, Morgan RS: Connective tissue reactions to implantation of purified sterol, sterol esters, phosphoglycerides, glycerides, and free fatty acids. J Pathol Bact 94, 63 (1967).
  • 83
    Ku DN, Giddens DP, Zarins CK, Glagov S: Pulsatile flow and atherosclerosis in the human carotid bifurcation. Arteriosclerosis 5, 293 (1985).
  • 84
    Friedman MH, Peters OJ, Bargeron CB, Hutchins GM, Mark FF: Shear-dependent thickening of the human arterial intima. Atherosclerosis 60, 161 (1986).
  • 85
    Schwartz CJ, Kelley JL, Nerem RM, Sprague EA, Rozek MM, Valente AJ, Edwards EH, Prasad ARS, Kerbacher JJ, Logan SA: Pathophysiology of the atherogenic process. Am J Cardiol 64, 23G (1989).
  • 86
    Parums DV, Chadwick DR, Mitchinson MJ: The localization of immunoglobulin in chronic periaortitis. Atherosclerosis 61, 117 (1986).
  • 87
    Emeson EE, Robertson AL: T lymphocytes in aortic and coronary intimas: Their potential role in atherogenesis. Am J Pathol 130, 369 (1988).
  • 88
    Hollander W, Colombo M, Small C: Further evidence that atherosclerosis is an autoimmune disease. Arteriosclerosis 10, 756a (1990).
  • 89
    Haberland ME, Fond D, Cheng L: Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241, 215 (1988).
  • 90
    Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler S, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: Low density lipoproteins undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86, 1372 (1989).
  • 91
    Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest 84, 1086 (1989).
  • 92
    Carew TE: Role of biologically modified low-density lipoprotein in atherosclerosis. Am J Cardiol 64, 18G (1989).
  • 93
    Roberts MJD, Young IS, Trouton TG, Trimble ER, Khan MM, Webb SW, Wison CM, Patterson GC, Adgey AAJ: Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 336, 143 (1990).
  • 94
    Glagov S, Weisenberg E, Zarins CK, Dilletis G, Stankunavicius R: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316, 1371 (1986).
  • 95
    von Rokitansky: A Manual of Pathological Anatomy. Syndenham Society, London (1852).
  • 96
    Mallory FB: The Harvey Lectures. JB Lippincott, Philadelphia (1912, 1913) 150.
  • 97
    Clark E, Graef I, Chasis H: Thrombosis of the aorta and coronary arterial with special reference to “fibrinoid” lesions. Arch Pathol 22, 183 (1936).
  • 98
    Duguid JB: Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J Pathol Bact 58, 207 (1946).
  • 99
    Schwartz CJ, Valente AJ, Kelley JL, Sprague EA, Edwards EH: Throbmosis and the development of atherosclerosis: Rokitansky revisited. Semi Throm Hemosta 14, 189 (1988).
  • 100
    Ardlie NG, Schwartz CJ: The organization and fate of autologous pulmonary emboli in hypercholesterolaemic rabbits. J Path Bact 95: 1929 (1968).
  • 101
    Ardlie NG, Sellay ML, Simons LA: Platelet activation by oxidatively modified low density lipoprotein. Atherosclerosis 76, 117 (1989).
  • 102
    Aviram M, Dankner G, Brook JG: Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity. Arteriosclerosis 10, 559 (1990).
  • 103
    Chandler AB, Chapman I, Erhardt LR, Roberts WC, Schwartz CJ, Sinapius D, Spain DM, Sherry S, Ness PM, Simon TL: Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol 34, 823 (1974).
  • 104
    Nerem RM, Levesque MJ, Cornhill JF: Vascular endothelial morphology as an indicator of patterns of blood flow. J Biomech Eng 103, 172 (1981).
  • 105
    Levesque MJ, Nerem RM: Elongation and orientation of cultured endothelial cells in response to shear. J Biomech Eng 107, 341 (1985).
  • 106
    Sprague EA, Steinbach BL, Nerem RM, Schwartz CJ: Influence of a laminar steady state fluid-imposed wall shear stress on the binding, internalization and degradation of low density lipoproteins (LDL) by cultured arterial endothelium. Circulation 76, 648 (1987).
  • 107
    de Sousa PA, Levesque MJ, Nerem RM: Electrophysiological response of endothelial cell to fluid-imposed shear stress. Fed Proc 45, 471 (1986).
  • 108
    Levesque MJ, Sprague EA, Schwartz CJ, Nerem RM: The influence of shear stress on cultured vascular endothelial cells: The stress response of an anchorage-dependent mammalian cell. Biotechnol Progr 5, 1 (1989).
  • 109
    Diamond SL, Eskin SG, McIntire LV: Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science 243, 1483 (1989).
  • 110
    Frangos JA, Eskin SG, McIntire LV, Ives CL: Flow effects on prostacyclin production by cultured human endothelial cells. Science 227, 1477 (1985).
  • 111
    Cayatte AJ, Schwartz CJ, Ncrem RM, Rozek MM, Sprague EA: Decreased adherence of platelets and monocytes to pre-endothelialized porous polyester mesh exposed to prolonged elevated shear stress. In Cardiovascular Science and Technology: Basic & Applied: I (Ed. NormanJ). Oxymoron Press Louisville, KY (1989) 57.
  • 112
    Dewey CF, Bussolari SR, Gimbrone M Jr, Davies PF: The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng 103, 177 (1981).
  • 113
    Levesque MJ, Nerem RM: Shear and pressure effects on cultured endothelial cells. Proc 36th Ann Engr Med Bio 1, 34 (1983).
  • 114
    Sato M, Levesque MJ, Nerem RM: Micropipette aspiration of cultured bovine aortic endothelial cells exposed to shear stress. Arteriosclerosis 7, 276 (1987).
  • 115
    Sprague EA, Moser M, Edwards EH, Schwartz CJ: Stimulation of receptor-mediated low density lipoprotein endocytosis in neuraminidase-treated cultured bovine aortic endothelial cells. J Cell Physiol 137, 251 (1988).
  • 116
    Prasad ARS, Nerem RM, Schwartz CJ, Sprague EA: Stimulation of phosphoinositide hydrolysis in bovine aortic endothelial cells exposed to elevated shear stress. J Cell Biol 109, 313a (1989).
  • 117
    Girard PR, Nerem RM: Role of protein kinase C in the transduction of shear stress to alterations in endothelial cell morphology. J Cell Biochem 14E, 210 (1990).
  • 118
    Dartsch PC, Betz E: Response of cultured endothelial cells to mechanical stimulation. Basic Res Cardiol 84, 268 (1989).
  • 119
    Gorfïen SF, Winston SK, Thibault LE, Macarak EJ: Effects of biaxial deformation on pulmonary artery endothelial cells. J Cell Physiol 139, 492 (1989).
  • 120
    Ives CL, Eskin SG, McIntire LV: Mechanical effects on endothelial cell morphology: In vitro assessment. In Vitro Cell Dev Biol 22, 500 (1986).
  • 121
    Shirinsky VP, Anonov AS, Birukov KG, Sobolevsky AV, Romanov YA, Kabaeva NV, Anonova GN, Smirnov VN: Mechano-chemical control of human endothelium orientation and size. J Cell Biol 109, 331 (1989).
  • 122
    Sumpio BE, Banes AJ, Levin LG, Johnson G Jr: Mechanical stress stimulates aortic endothelial cells to proliferate. J Vasc Surg 6, 252 (1987).
  • 123
    Sumpio BE, Banes AJ, Buckley M, Johnson G: Alterations in aortic endothelial cell morphology and cytoskeletal protein synthesis during cyclic tensional deformation. J Vasc Surg 7, 130 (1988).
  • 124
    Sumpio BE, Banes AJ: Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic stretch. Surgery 104, 383 (1988).
  • 125
    Wissler RW: Current status of regression studies. In Atherosclerosis Reviews 3 (Eds. PaolettiR, GottoAM). Raven Press, New York (1978) 213.
  • 126
    Blankenhorn DH, Nessim SA, Johnson RD, Sanmarco ME, Azen SP, Cashin-Hemphill L: Beneficial effects of combined Colestipol-Niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. J Am Med Assoc 257, 3233 (1987).
  • 127
    Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B: Effects of probucol on xanthoma regression in familial hypercholesterolemia. Am J Cardiol 57, 29H (1986).
  • 128
    Witztum JL, Simmons D, Steinberg D, Beltz WF, Weinreb R, Young SG, Lester P, Kelly N, Juliano J: Intensive drug therapy of familial hypercholesterolemia with Lovastatin, Probucol, and Colestipol Hydrochloride. Circulation 79, 16 (1989).
  • 129
    Wissler RW, Vesselinovitch D: Combined effects of cholestyramine and probucol on regression of atherosclerosis in Rhesus monkey aortas. Appl Pathol 1, 89 (1983).
  • 130
    Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C: Probucol prevents the progression of atherosclerosis in Watanabe Heritable Hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84, 5928 (1987).
  • 131
    Kita T, Yokode M, Ishii K, Kume N, Ootani H, Arai H, Narumiya S: New ways to utilize the WHHL rabbits to study atherosclerosis and ischemic heart disease. In Atherosclerosis VIII (Eds. CrepaldiG, GottoAM, ManzatoE, BaggioG). Excerpta Medica, International Congress Series 817 (1989) 129.
  • 132
    Steinberg D, Parthasarathy S, Carew TE: In vivo inhibition of foam cell development by Probucol in Watanabe rabbits. Am J Cardiol 62, 6B (1988).
  • 133
    McPherson R, Hogue M, Milne R, Tall AR, Marcel YL: Effects of Probucol on plasma concentrations of cholesteryl ester transfer protein. Proc Xth International Meeting on Drugs Affecting Lipid Metabolism. Elsevier Publishing B.V., Amsterdam, in press (1990).
  • 134
    Schwartz CJ, Sprague EA, Valente AJ, Kelley JL, Edwards EH, Suenram CA: Inflammatory components of the human atherosclerotic plaque. In Pathobiology of the Human Atherosclerotic Plaque (Eds. GlagovS, NewmanWPIII, SchafferSA). Springer-Verlag, New York (1990) 107.
  • 135
    Valente AJ, Rozek MM, Graves DT, Schwartz CJ: Demonstration of specific receptors for MCP-I on peripheral blood monocytes. Submitted (1990).